The results showed that overexpression of FHL1 could significantly inhibit the expression of p-GSK-3, active-β-catenin and the downstream molecules LEF1 and TCF4 in the Wnt/β-catenin signaling pathway in CRC cells. Here, FHL1 is linked to colorectal carcinoma.